Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations

被引:58
|
作者
Halseth, AE [1 ]
Ensor, NJ [1 ]
White, TA [1 ]
Ross, SA [1 ]
Gulve, EA [1 ]
机构
[1] Pharmacia Corp, Cardiovasc & Metab Dis, St Louis, MO 63167 USA
关键词
5 ' AMP-activated kinase; diabetes; skeletal muscle; triglycerides; Glut4;
D O I
10.1016/S0006-291X(02)00557-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme 5'AMP-activated protein kinase (AMPK) is activated by increases in intracellular AMP concentration through a complex interaction of phosphorylation and allosteric regulation. Actions of AMPK elucidated thus far suggest that AMPK may be a viable target for pharmacololgic intervention in type II diabetes. Activation of AMPK is believed to mediate both the acute increase in skeletal muscle glucose uptake during exercise, as well as the adaptive responses to chronic exercise such as regulation of expression of components of the muscle glucose uptake system. In addition. AMPK is known to inhibit key enzymes involved ill lipid and cholesterol synthesis, suggesting that activation of this kinase may also ameliorate dyslipidemia. To investigate the effects of AMPK activation in animal models of type II diabetes, db/db and ob/ob mice were administered 5-aminoimidazole-4-calbox-amide 1-beta-ribofuranoside (A1CAR) Subcutaneously either acutely (single injection) or m ice per clay for 8 days (chronic treatment). Blood glucose was lowered transiently in both db/db and ob/ob mice by acute A1CAR treatment, returning to basal levels similar to3 h after A1CAR administration. In response to chronic treatment, blood glucose (measured 18 h post-A1CAR administration) was significantly decreased in both mouse models when compared to vehicle control groups, with morning blood glucose values oil Day 8 being decreased similar to30-35% in both Mouse models. Chronic A1CAR administration also resulted in ail elevation of total Glut4 concentration in skeletal muscle from ob/ob mice, but not db/db mice. In contrast to the beneficial effects on glucose metabolism, A1CAR treatment of db/db and ob/ob mice led to approximately a 2.5-3-fold increase in serum triglyceride levels compared to vehicle-treated controls. These data Suggest that pharmacological activation of AMPK may enhance glucose uptake in individuals with type II diabetes, however, this benefit may be offset by the concomitant elevation in triglycerides. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:798 / 805
页数:8
相关论文
共 50 条
  • [41] Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin
    Suriano, Franc
    Vieira-Silva, Sara
    Falony, Gwen
    Roumain, Martin
    Paquot, Adrien
    Pelicaen, Rudy
    Regnier, Marion
    Delzenne, Nathalie M.
    Raes, Jeroen
    Muccioli, Giulio G.
    Van Hul, Matthias
    Cani, Patrice D.
    MICROBIOME, 2021, 9 (01)
  • [42] Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota
    Suriano, Francesco
    Manca, Claudia
    Flamand, Nicolas
    Depommier, Clara
    Van Hul, Matthias
    Delzenne, Nathalie M.
    Silvestri, Cristoforo
    Cani, Patrice D.
    Di Marzo, Vincenzo
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2022, 1867 (01):
  • [43] Pioglitazone alleviates β-cell stress and improves β-cell function in KKA (y), ob/ob, and db/db mice
    Diani, A
    Sawada, G
    Murray, F
    DIABETES, 2003, 52 : A116 - A116
  • [44] Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin
    Francesco Suriano
    Sara Vieira-Silva
    Gwen Falony
    Martin Roumain
    Adrien Paquot
    Rudy Pelicaen
    Marion Régnier
    Nathalie M. Delzenne
    Jeroen Raes
    Giulio G. Muccioli
    Matthias Van Hul
    Patrice D. Cani
    Microbiome, 9
  • [45] ALTERED SYNAPTOSOMAL NOREPINEPHRINE UPTAKE OF THE HYPOTHALAMUS IN GENETICALLY-OBESE (OB OB) AND DIABETIC (DB DB) MICE
    SHIMIZU, H
    MORI, M
    KOBAYASHI, I
    NEUROENDOCRINOLOGY LETTERS, 1991, 13 (06) : 425 - 430
  • [46] HYPERINSULINEMIA AND FAT-CELL GLYCEROKINASE ACTIVITY IN OBESE (OB-OB) AND DIABETIC (DB-DB) MICE
    THENEN, SW
    MAYER, J
    HORMONE AND METABOLIC RESEARCH, 1976, 8 (01) : 80 - 81
  • [47] Skin barrier homeostasis is impaired in type 2 diabetes mellitus animal models such as db/db and ob/ob mice
    Kim, J.
    Park, H.
    Jung, M.
    Choi, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S51 - S51
  • [48] DIURNAL RHYTHM FOR CORTICOSTERONE IN OBESE (OB/OB) DIABETES (DB/DB) AND GOLD-THIOGLUCOSE-INDUCED OBESITY IN MICE
    SAITO, M
    BRAY, GA
    ENDOCRINOLOGY, 1983, 113 (06) : 2181 - 2185
  • [49] RESPONSE OF OBESE (OB-OB) AND DIABETIC (DB-DB) MICE TO TREATMENTS THAT INFLUENCE BODY-TEMPERATURE
    YEN, TT
    FULLER, RW
    PEARSON, DV
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY, 1974, 49 (2A): : 377 - 385
  • [50] Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet
    Trak-Smayra, Viviane
    Paradis, Valerie
    Massart, Julie
    Nasser, Selim
    Jebara, Victor
    Fromenty, Bernard
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2011, 92 (06) : 413 - 421